208 related articles for article (PubMed ID: 25827356)
1. Inferring mutational timing and reconstructing tumour evolutionary histories.
Turajlic S; McGranahan N; Swanton C
Biochim Biophys Acta; 2015 Apr; 1855(2):264-75. PubMed ID: 25827356
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding tumour evolution through single-cell sequencing.
Kuipers J; Jahn K; Beerenwinkel N
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):127-138. PubMed ID: 28193548
[TBL] [Abstract][Full Text] [Related]
3. Constraints in cancer evolution.
Venkatesan S; Birkbak NJ; Swanton C
Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
[TBL] [Abstract][Full Text] [Related]
4. Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.
Barber LJ; Davies MN; Gerlinger M
Curr Opin Genet Dev; 2015 Feb; 30():1-6. PubMed ID: 25555261
[TBL] [Abstract][Full Text] [Related]
5. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
6. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.
McGranahan N; Favero F; de Bruin EC; Birkbak NJ; Szallasi Z; Swanton C
Sci Transl Med; 2015 Apr; 7(283):283ra54. PubMed ID: 25877892
[TBL] [Abstract][Full Text] [Related]
7. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
[TBL] [Abstract][Full Text] [Related]
8. Learning mutational graphs of individual tumour evolution from single-cell and multi-region sequencing data.
Ramazzotti D; Graudenzi A; De Sano L; Antoniotti M; Caravagna G
BMC Bioinformatics; 2019 Apr; 20(1):210. PubMed ID: 31023236
[TBL] [Abstract][Full Text] [Related]
9. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
Caswell DR; Swanton C
BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
[TBL] [Abstract][Full Text] [Related]
10. Resolving genetic heterogeneity in cancer.
Turajlic S; Sottoriva A; Graham T; Swanton C
Nat Rev Genet; 2019 Jul; 20(7):404-416. PubMed ID: 30918367
[TBL] [Abstract][Full Text] [Related]
11. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
[TBL] [Abstract][Full Text] [Related]
12. Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
Andersson N; Bakker B; Karlsson J; Valind A; Holmquist Mengelbier L; Spierings DCJ; Foijer F; Gisselsson D
Cancer Res; 2020 Apr; 80(7):1512-1523. PubMed ID: 32041836
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Murtaza M; Dawson SJ; Tsui DW; Gale D; Forshew T; Piskorz AM; Parkinson C; Chin SF; Kingsbury Z; Wong AS; Marass F; Humphray S; Hadfield J; Bentley D; Chin TM; Brenton JD; Caldas C; Rosenfeld N
Nature; 2013 May; 497(7447):108-12. PubMed ID: 23563269
[TBL] [Abstract][Full Text] [Related]
14. Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data.
Malikic S; Jahn K; Kuipers J; Sahinalp SC; Beerenwinkel N
Nat Commun; 2019 Jun; 10(1):2750. PubMed ID: 31227714
[TBL] [Abstract][Full Text] [Related]
15. Catch my drift? Making sense of genomic intra-tumour heterogeneity.
Sottoriva A; Barnes CP; Graham TA
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):95-100. PubMed ID: 28069394
[TBL] [Abstract][Full Text] [Related]
16. Principles of Reconstructing the Subclonal Architecture of Cancers.
Dentro SC; Wedge DC; Van Loo P
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28270531
[TBL] [Abstract][Full Text] [Related]
17. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
18. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
Horswell S; Matthews N; Swanton C
Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
[TBL] [Abstract][Full Text] [Related]
19. Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.
Hollstein M; Alexandrov LB; Wild CP; Ardin M; Zavadil J
Oncogene; 2017 Jan; 36(2):158-167. PubMed ID: 27270430
[TBL] [Abstract][Full Text] [Related]
20. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
